Annexon (ANNX)
Develops C1q-targeted therapies for complement-mediated diseases of the body, eye, and brain.
$3.96
vs last close−0.22 (−5.38%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 47 days
EPS estimate
−$0.28
Revenue estimate
$3.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.33−$0.37−$0.34−$0.37−$0.28−$0.23−$0.28Pending
Estimate−$0.28−$0.30−$0.36−$0.34−$0.32−$0.30−$0.24−$0.28
Surprise−17.9%−23.3%+5.6%−8.8%+12.5%+23.3%−17.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————$3.3M$5.5M$6.5M$3.5M
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.26 | — | — |
| Sep 2028 | −$0.30 | — | — |
| Jun 2028 | −$0.28 | — | — |
| Mar 2028 | −$0.26 | — | — |
| Dec 2027 | −$0.25 | — | — |
| Sep 2027 | −$0.30 | — | — |
| Jun 2027 | −$0.29 | — | — |
| Mar 2027 | −$0.23 | — | — |
| Dec 2026 | −$0.27 | — | — |
| Nov 2026 | −$0.28 | — | — |
| Aug 2026 | −$0.24 | −$0.28 | −17.2% |
| May 2026 | −$0.30 | −$0.23 | +23.3% |
| Mar 2026 | −$0.32 | −$0.28 | +12.5% |
| Nov 2025 | −$0.34 | −$0.37 | −8.8% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Sep 2020 | |||
| Jul 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.26 | — | — | $30.4M | — | — | — |
| Sep 2028 | −$0.30 | — | — | $16.9M | — | — | — |
| Jun 2028 | −$0.28 | — | — | $11.5M | — | — | — |
| Mar 2028 | −$0.26 | — | — | $6.6M | — | — | — |
| Dec 2027 | −$0.25 | — | — | $24.3M | — | — | — |
| Sep 2027 | −$0.30 | — | — | $4.1M | — | — | — |
| Jun 2027 | −$0.29 | — | — | $2.7M | — | — | — |
| Mar 2027 | −$0.23 | — | — | $15.5M | — | — | — |
| Dec 2026 | −$0.27 | — | — | $7.5M | — | — | — |
| Nov 9, 2026 | −$0.28 | — | — | $3.5M | — | — | — |
| Aug 12, 2026 | −$0.24 | −$0.28 | −17.2% | $6.5M | — | — | −0.2% |
| May 7, 2026 | −$0.30 | −$0.23 | +23.3% | $5.5M | — | — | −3.2% |
| Mar 30, 2026 | −$0.32 | −$0.28 | +12.5% | $3.3M | — | — | −0.8% |
| Nov 10, 2025 | −$0.34 | −$0.37 | −8.8% | — | — | — | +3.5% |
| Aug 14, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 3, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 26, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 8, 2023 | |||||||
| Mar 6, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Sep 8, 2020 | |||||||
| Jul 24, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |